Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC grew its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,952,442 shares of the company's stock after buying an additional 95,458 shares during the quarter. Geode Capital Management LLC owned 1.58% of Doximity worth $157,668,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in DOCS. Global Retirement Partners LLC increased its stake in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after acquiring an additional 235 shares during the last quarter. Larson Financial Group LLC increased its position in shares of Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors acquired a new position in Doximity in the 4th quarter valued at $43,000. Finally, Morse Asset Management Inc purchased a new position in Doximity in the 3rd quarter valued at $46,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 37.40% of the stock is currently owned by company insiders.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded up $1.30 during trading on Friday, hitting $52.87. The company's stock had a trading volume of 2,195,590 shares, compared to its average volume of 1,977,462. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The business has a 50 day moving average price of $64.74 and a two-hundred day moving average price of $55.49. The company has a market capitalization of $9.87 billion, a PE ratio of 52.87, a P/E/G ratio of 4.10 and a beta of 1.41.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of recent research reports. The Goldman Sachs Group increased their target price on shares of Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Leerink Partnrs raised shares of Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Canaccord Genuity Group boosted their target price on Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a report on Friday, February 7th. Stephens assumed coverage on Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target for the company. Finally, Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and lifted their price objective for the stock from $60.00 to $90.00 in a research report on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Doximity presently has an average rating of "Moderate Buy" and a consensus target price of $64.72.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.